What We’re Reading, July 25, 2016: Keeping dementia at bay in the elderly; PhRMA spends more and insurers spend less on lobbying, so far in 2016; and a record-breaking fraud case in Florida.
Keeping the brains of older adults active via a digital training exercise can reduce the risk of dementia, according to a study that was presented at the Alzheimer’s Association International Conference in Toronto. STAT news reports that the ACTIVE (Advanced Cognitive Training for Independent and Vital Elderly) study, initiated in 1998, followed more than 2800 older adults (74 years and older when recruited) who received 1 of 3 forms of cognitive training or none. While 14% of participants in the untrained group developed dementia a decade later, only 8.2% of those who completed 10 sessions of computer-based training developed dementia.
The Pharmaceutical Research and Manufacturers of America (PhRMA) has already spent close to $12 million on lobbying efforts so far this year, according to The Commonwealth Fund. With providers and insurance companies spending less this year compared with the same period last year, and the increased focus on election campaigns, PhRMA is focused on defending its members from concerns over prescription drug costs. Lobbying arms representing the health insurance industry and healthcare provider groups, on the other hand, have spent less so far. The American Medical Association, for instance, has spent just about one-third the amount compared with this time last year.
Another fraud case filed by the justice department is a record breaker—the owner of a network of Florida nursing facilities has been charged with cheating Medicare and Medicaid for nearly a decade and a half to the tune of more than a billion dollars. The owner, Philip Esformes, along with his accomplices, rotated 14,000 elderly people through his nursing homes and assisted-living places regardless of their needs. “This was a whole network of people scratching each other’s backs, paying kickbacks and giving each other referrals. It shows what people can do when they’re determined to put their hand in the Medicare pot,” said Leslie R. Caldwell, who leads the Justice Department’s criminal division
Neurologists Share Tips for Securing Patient Access to Gene Therapies
March 19th 2025Tenacious efforts at every level, from the individual clinician to the hospital to the state to Congress, will be needed to make sure patients can access life-saving gene therapies for neuromuscular diseases.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
The Impact of Cost Sharing on High-Value Care
March 14th 2025Michael Chernew, PhD, professor of health care policy and director of the Healthcare Markets and Regulation Lab, Harvard Medical School, shares how cost-sharing policies shape access to critical health care services and influence value-based insurance design.
Read More